Collaborative personalized-medicine project for Manuel Schröter

Together with Verdon Taylor (University of Basel) Manuel Schröter initiated a project to study the physiology and degeneration of human dopaminergic neurons in Parkinson’s disease within the Basel Personal Medicine Initiative. The project focuses on neurons that produce the neurotransmitter dopamine and their role in one of the most prominent human neurological disorders, Parkinson’s disease. Diseased cells, similar to those found in patients suffering from Parkinson’s disease, will be used to test different drugs that could potentially rescue the functioning of dopaminergic neurons. This study will improve the understanding of neuronal physiology in Parkinson’s disease and provide valuable information for the development of personalised therapies for this severe neurological disorder.

The Basel Personalised Medicine Initiative is funding joint projects in the broad area of personalised medicine between members of D-BSSE and the University of Basel.